PALO ALTO, Calif., Oct. 24, 2017 /PRNewswire/ -- Varian (NYSE: VAR) today announced five patients with brain cancer became
"We have been doing preclinical and clinical development of single isocenter radiosurgery for a decade," said John Fiveash, M.D., professor and vice chair for academic programs in the UAB Department of Radiation Oncology. "Over the last five years, our radiosurgery plan quality has improved to equal or exceed our Gamma Knife. Physicians and patients preferred the frameless and highly efficient delivery on our TrueBeam and Edge systems and our Gamma Knife was decommissioned June 2017. HyperArc planning automates much of the radiosurgery treatment planning strategies that we have implemented at UAB and could enable more clinics to perform higher quality radiosurgery for more patients."
"Working closely with leading institutions like UAB played an important role in the development of HyperArc," said Kolleen Kennedy, president of Varian's Oncology Systems business. "We value their continued contributions to the advancement of cancer care and we are excited that HyperArc treatments have now begun in the US."
HyperArc capitalizes on the unique capabilities of Varian's TrueBeam™ and EDGE™ treatment systems. HyperArc treatments allow clinicians the ability to deliver more compact radiation doses that closely conform to the size, shape, and location of tumors while sparing more surrounding healthy tissue. These advanced treatments can be delivered in a conventional treatment time slot. The treatment planning for HyperArc is supported by Varian's Eclipse™ treatment planning software.
For more information on HyperArc, visit www.varian.com/hyperarc
About Varian Medical SystemsVarian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,600 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Mark PlungyVarian Medical Systems+1 (650) 424-5630 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/first-patients-in-us-treated-with-varian-hyperarc-high-definition-radiotherapy-300541755.html
SOURCE Varian Medical Systems
Subscribe to our Free Newsletters!
Donating blood is a life-saving act. Consider increasing your iron intake before and after you ...
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...View All